Literature DB >> 19225098

Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis.

Jennifer S Goodrich1, Tameaka N Sutton-Shields, Alan Kerr, Joel P Wedd, Melissa B Miller, Peter H Gilligan.   

Abstract

We prospectively determined the prevalence of community-associated Staphylococcus aureus in a large cystic fibrosis (CF) center between October 2005 and October 2007. We found that 2.7% (19/707) of the CF patients who had cultures during the study period were infected with this organism, representing 14% of the total methicillin-resistant Staphylococcus aureus strains (n = 140) recovered from the patient population during the study period.

Entities:  

Mesh：

Year:  2009        PMID： 19225098      PMCID： PMC2668292          DOI： 10.1128/JCM.00255-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States.

Authors:  Fred C Tenover; Linda K McDougal; Richard V Goering; George Killgore; Steven J Projan; Jean B Patel; Paul M Dunman
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes.

Authors:  John S Francis; Meg C Doherty; Uri Lopatin; Cecilia P Johnston; Gita Sinha; Tracy Ross; Mian Cai; Nadia N Hansel; Trish Perl; John R Ticehurst; Karen Carroll; David L Thomas; Eric Nuermberger; John G Bartlett
Journal:  Clin Infect Dis       Date:  2004-12-07       Impact factor: 9.079

4.  Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins.

Authors:  G Supersac; G Prevost; Y Piemont
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

5.  Gene sequences and specific detection for Panton-Valentine leukocidin.

Authors:  Saori Nakagawa; Ikue Taneike; Daigo Mimura; Nobuhiro Iwakura; Teruko Nakayama; Tomoko Emura; Maki Kitatsuji; Atsushi Fujimoto; Tatsuo Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2005-03-25       Impact factor: 3.575

6.  Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.

Authors:  Elliott C Dasenbrook; Christian A Merlo; Marie Diener-West; Noah Lechtzin; Michael P Boyle
Journal:  Am J Respir Crit Care Med       Date:  2008-07-31       Impact factor: 21.405

7.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

8.  Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Authors:  G Prévost; B Cribier; P Couppié; P Petiau; G Supersac; V Finck-Barbançon; H Monteil; Y Piemont
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes.

Authors:  V Finck-Barbançon; G Duportail; O Meunier; D A Colin
Journal:  Biochim Biophys Acta       Date:  1993-10-20

10.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
View more
  12 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.

Authors:  Marianne S Muhlebach; Sonya L Heltshe; Elena B Popowitch; Melissa B Miller; Valeria Thompson; Margaret Kloster; Thomas Ferkol; Wynton C Hoover; Michael S Schechter; Lisa Saiman
Journal:  Ann Am Thorac Soc       Date:  2015-06

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers.

Authors:  Melissa B Miller; David J Weber; Jennifer S Goodrich; Elena B Popowitch; Michele D Poe; Viet Nyugen; Timothy R Shope; David T Foster; James R Miller; Jonathan Kotch
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

6.  Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients.

Authors:  V Cafiso; T Bertuccio; D Spina; F Campanile; D Bongiorno; M Santagati; A Sciacca; C Sciuto; S Stefani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-04       Impact factor: 3.267

7.  Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.

Authors:  Sonya L Heltshe; Lisa Saiman; Elena B Popowitch; Melissa B Miller; Margaret Kloster; Valeria Thompson; Thomas W Ferkol; Wynton C Hoover; Michael S Schechter; Marianne S Muhlebach
Journal:  J Pediatric Infect Dis Soc       Date:  2014-06-09       Impact factor: 3.164

8.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis.

Authors:  Duha Al-Zubeidi; Patrick G Hogan; Mary Boyle; Carey-Ann D Burnham; Stephanie A Fritz
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

9.  Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method.

Authors:  Hoang Vu-Thien; Katia Hormigos; Gaëlle Corbineau; Brigitte Fauroux; Harriet Corvol; Didier Moissenet; Gilles Vergnaud; Christine Pourcel
Journal:  BMC Microbiol       Date:  2010-01-27       Impact factor: 3.605

10.  Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis.

Authors:  Deirdre Gilpin; Lucas R Hoffman; Agathe Ceppe; Marianne S Muhlebach
Journal:  J Cyst Fibros       Date:  2021-06-06       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.